ZYUS Life Sciences Corporation (TSXV: ZYUS)

ZYUS Life Sciences Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020
Net Income	-36.55	-42.59	-24.66	-23.46	-25.09
Depreciation & Amortization	2.98	3.11	3.06	2.52	1.36
Other Amortization	-	-	0.98	1.26	0.06
Loss (Gain) From Sale of Assets	-	-	-	-	-0.24
Asset Writedown & Restructuring Costs	22.77	22.77	2.09	-	3.24
Stock-Based Compensation	0.56	0.27	0.11	0.62	1.56
Other Operating Activities	-2.99	3.25	6.22	0.03	0.03
Change in Accounts Receivable	0.12	-0.35	0.11	0.33	0.68
Change in Inventory	-0.15	-0.02	0.45	-0.17	-4.87
Change in Accounts Payable	2.86	-5.12	2.34	1.93	3.71
Change in Other Net Operating Assets	3.02	0.67	-0.27	0.08	-1.12
Operating Cash Flow	-7.39	-18.01	-9.57	-16.86	-20.68
Capital Expenditures	-0.24	-0.28	-0.56	-4.99	-5.45
Sale of Property, Plant & Equipment	-	-	-	-	0.29
Cash Acquisitions	-	4.92	-0.03	-	-
Sale (Purchase) of Intangibles	-	-	-	-0	-0.52
Investing Cash Flow	-0.24	4.64	-0.59	-4.99	-5.68
Short-Term Debt Issued	-	0.35	3.04	-	-
Long-Term Debt Issued	-	20.89	6.76	11.63	10.99
Total Debt Issued	0.7	21.24	9.8	11.63	10.99
Short-Term Debt Repaid	-	-3.29	-0.1	-	-
Long-Term Debt Repaid	-	-0.82	-0.24	-0.03	-0.45
Total Debt Repaid	-3.36	-4.11	-0.34	-0.03	-0.45
Net Debt Issued (Repaid)	-2.66	17.14	9.45	11.6	10.54
Issuance of Common Stock	3.31	-	0.18	3.01	0.16
Financing Cash Flow	0.66	17.14	9.63	14.61	14.68
Net Cash Flow	-6.97	3.77	-0.54	-7.24	-11.68
Free Cash Flow	-7.63	-18.29	-10.13	-21.85	-26.13
Free Cash Flow Margin	-1687.83%	-5211.68%	-3400.67%	-10553.14%	-
Free Cash Flow Per Share	-0.11	-0.33	-0.26	-0.43	-0.54
Cash Interest Paid	0.28	0.23	0.11	0.9	0.13
Levered Free Cash Flow	-2.63	-14.89	-5.66	-12.36	-
Unlevered Free Cash Flow	-2.28	-12.85	-2.38	-11.45	-
Change in Net Working Capital	-6.23	3.83	-4.47	-3.37	-

Source: S&P Capital IQ. Standard template. Financial Sources.